Background Image
Table of Contents Table of Contents
Previous Page  541 / 772 Next Page
Information
Show Menu
Previous Page 541 / 772 Next Page
Page Background

11

Morningstar FundInvestor

December

2015

Valeant Pharmaceuticals

VRX

recent plunge—and

the pain endured by its largest shareholders—

highlights the risks of taking large bets on individual

companies. Several fund managers held sizable

stakes in the stock, though

Sequoia

SEQUX

stood out

for its position, which reached

29%

of fund assets

in mid-

2015

. The fund lost

22%

from August

2015

to

November

2015

as Valeant’s stock price fell

65%

on

allegations of fraud and aggressive pricing practices.

That’s not to say investors should avoid concentrated

funds. Patient investors with long horizons may find

much to like with them. In fact, Morningstar’s fund

analysts assign Sequoia a Morningstar Analyst Rating

of Gold, reflecting their view that it’s a best-of-breed

fund for investors willing to ride out short-term bumps.

Still, it’s worth noting when a fund’s concentration

markedly changes. Some fund shareholders certainly

noticed that Sequoia’s stake in Valeant had more

than tripled as a percentage of the portfolio during

the past three years. Keeping an eye on such changes

helps keep investors apprised of the risks they face.

To identify situations where concentration risk has

grown, we screened the Morningstar

500

for

funds that have meaningfully increased their alloca-

tion to their top

10

holdings during the past three

years. While the funds below don’t carry as much

stock-specific risk as Sequoia, the recent changes

still merit consideration.

Royce Special Equity Multi-Cap

RSMCX

and

Royce

Special Equity

RYSEX

have become considerably

more concentrated in the past three years. The top

10

stock holdings grew to

58%

of assets from

34%

in the former, and to

48%

of assets from

33%

in the

latter. Each fund currently keeps more than

7%

of

assets in its largest holding, compared with less than

4%

three years ago. As the market rally gets long

in the tooth, manager Charlie Dreifus says he’s found

more names to sell than buy. He’s a stickler on valua-

tions and faces the challenge many value managers

do after a long rally. His strong record of managing

risk is comforting. Still, the funds’ recent change in

complexion bears monitoring. Several top names have

turned in double-digit losses in the year to date

through November

2015

.

Westport

WPFRX

has also consolidated its portfolio.

During the past three years, the fund’s number

of positions has fallen to

32

from

50

, while its top

10

names have grown to

54%

of assets from

31%

. It’s

nice to see that the top holdings have long held spots

in the portfolio.

Universal Health Sciences

UHS

,

the largest position at

8%

of assets, was first bought

in December

2008

, and all of the other top

10

names

were purchased in

2011

or earlier. Longtime skipper

Ed Nicklin is in his late

60

s, and the firm’s co-owner

Andy Knuth is in his mid-

70

s, which raises concerns

about succession planning, another red flag.

Delafield Fund

has about

40%

of assets in its top

10

positions, marking a notable increase from

25%

three years ago. It focuses on small- and mid-cap

companies and holds no more than

5%

of assets in

any stock. While that may not seem to court sig-

nificant company-specific risk, the fund stands out

versus small- and mid-cap competitors, which

tend to have more-diversified portfolios compared

with large-cap strategies. The average small-cap

fund holds

22%

of assets in its top

10

holdings, while

the typical mid-cap strategy stashes about

27%

of assets in its

10

largest positions. Delafield is also

concentrated from a sector standpoint, with

82%

of the portfolio invested in just three sectors: materials,

industrials, and information technology.

K

Contact Leo Acheson at

leo.acheson@morningstar.com

Rising Concentration Points to

New Risks

Red Flags

|

Leo Acheson

What is Red Flags?

Red Flags is designed to alert

you to funds’ hidden risks. Such

risks can take many forms,

including asset bloat, the

departure of a solid manager, or

a focus on an overhyped asset

class. Not every fund featured

in Red Flags is a sell, and in fact,

some are good long-term

holdings. But investors should

be prepared for a potentially

bumpier ride in the near future.